home new2022-10-13T14:54:37-07:00
[rev_slider alias=”slider-3″ /]

Featured Articles

PLEOPHARMA TO PRESENT NEWDATA ON CANNABIS WITHDRAWAL In PATIENTS WITH CANNABIS USE DISORDER AND PHASE 2 PP-01 RESULTS AT THE COLLEGE ON PROBLEMS OF DRUG DEPENDENCE 88TH ANNUAL SCIENTIFIC MEETING

Presentations will highlight the patient experience of cannabis withdrawal/cannabis use disorder and Phase 2 CAN-002 data for investigational PP-01 in adults with cannabis use disorder PHOENIXVILLE, Pa., June 15, 2026 /PRNewswire/ -- PleoPharma, a clinical-stage clinical development company focused on cannabis-related health issues, announced today that it will present two posters...

HUD Secretary: Regulatory Environment Hindering Housing

Housing and Urban Development (HUD) Secretary Scott Turner recently stressed that the Trump Administration has been intentional about tearing down the regulatory environment that many have blamed as a cause for housing affordability across America. Appearing on CNBC, the conversation focused on regulatory burdens that officials say add roughly $100,000...

Tesla’s FSD Safety Claims Face Scrutiny in Europe

Tesla is once under fire from critics of its Full Self-Driving driver-assistance system, this time in Europe. The problem popped up after Reuters reported that the automaker presented self-published statistics to European regulators that independent traffic-safety experts say exaggerate FSD’s benefits. The timing comes as Tesla is looking to get...

Featured STOCK

 
Go to Top